Sign up to save your podcasts
Or
Share Enzolytics, Inc. Discusses the Significance and Revenue Potential of Its Therapeutic Platforms with The Stock Day Podcast
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Enzolytics, Inc. Discusses the Significance and Revenue Potential of Its Therapeutic Platforms with The Stock Day Podcast
The Stock Day Podcast welcomed Enzolytics, Inc. (ENZC) (“the Company”), a drug development company committed to commercializing its proprietary proteins and monoclonal antibodies to treat debilitating infectious diseases. Director and COO of the Company, Dr. Gaurav Chandra, joined Stock Day host Everett Jolly
Advertising Inquiries: https://redcircle.com/brands
Privacy & Opt-Out: https://redcircle.com/privacy
View all episodes
By Stock Day Media
4.4
3131 ratings
The Stock Day Podcast welcomed Enzolytics, Inc. (ENZC) (“the Company”), a drug development company committed to commercializing its proprietary proteins and monoclonal antibodies to treat debilitating infectious diseases. Director and COO of the Company, Dr. Gaurav Chandra, joined Stock Day host Everett Jolly
Advertising Inquiries: https://redcircle.com/brands
Privacy & Opt-Out: https://redcircle.com/privacy
More shows like Stock Day Media
View all
Bad Friends
14,178 Listeners